Kato Medical Group Showcases Embryology Research at ESHRE 42nd Annual Meeting

Kato Medical Group continues to contribute to the advancement of reproductive medicine through research and scientific collaboration on the global stage. During the ESHRE 42nd Annual Meeting in the United Kingdom, our Chief Embryologist, Ms. Elaine Pasamba, presented the study entitled “Beyond Single Morphological Metrics: Integrating Oocyte Diameter and Artificial Intelligence-Based Scoring Improves Prediction of Developmental Competence and Implantation.”

The research represents the collective efforts and dedication of Kato Medical Group’s Embryology Team in exploring innovative approaches to embryo selection and assisted reproductive technology. By integrating oocyte diameter measurements with artificial intelligence-based scoring, the study aims to enhance the prediction of developmental competence and implantation potential, providing valuable insights that may contribute to improved IVF outcomes.

Presented before an international audience of fertility specialists, embryologists, and researchers, the study reflects Kato Medical Group’s commitment to evidence-based practice and continuous innovation in reproductive healthcare. It also underscores the important role of collaboration within our laboratory, where scientific curiosity and teamwork drive meaningful advancements in patient care.

As we continue to participate in international scientific forums, Kato Medical Group remains dedicated to expanding knowledge, embracing emerging technologies, and advancing fertility care—bringing hope to more individuals and families striving to achieve their dream of parenthood.